Accelerated Intermittent Theta-Burst Stimulation Aids Treatment-Resistant Bipolar Depression
By Lori Solomon HealthDay Reporter
WEDNESDAY, July 24, 2024 -- Accelerated intermittent theta-burst stimulation (aiTBS) is significantly more effective than sham stimulation for depressive symptom reduction in patients with treatment-resistant bipolar depression, according to a study published online July 10 in JAMA Psychiatry.
Yvette I. Sheline, M.D., from the University of Pennsylvania Perelman School of Medicine in Philadelphia, and colleagues assessed whether aiTBS is clinically effective for treatment-refractory bipolar depression. Analysis included 24 participants randomly assigned to active (12 patients) or sham (12 patients) aiTBS. The intervention included 10 sessions per day of imaging-guided active or sham aiTBS for five days with one session per hour at 90 percent resting motor threshold for 90,000 pulses total.
The researchers found that at one month follow-up, Montgomery-Åsberg Depression Rating Scale scores were significantly lower in the active group (mean, 30.4 at baseline; 10.5 after treatment) than in the sham group (28.0 at baseline; 25.3 after treatment).
"The findings suggest that aiTBS in carefully selected patients offers a new treatment option for this difficult-to-treat illness," the authors write. "Further trials are needed to determine aiTBS durability and to compare with other treatments."
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted July 2024
Read this next
Cutting Screen Use Boosts Mental Health in Children, Teens
WEDNESDAY, July 24, 2024 -- Short-term reduction in leisure-time screen media use within families positively affects psychological symptoms in children and adolescents, according...
Depression, Anxiety, Fibromyalgia Common With Rheumatoid Arthritis, Osteoarthritis
WEDNESDAY, July 24, 2024 -- Approximately four in 10 patients with osteoarthritis (OA) or rheumatoid arthritis (RA) have anxiety, depression, or fibromyalgia, according to a study...
Mediterranean Diet May Aid Mental Health in Rheumatoid Arthritis Patients
TUESDAY, July 23, 2024 -- Greater adherence to a Mediterranean diet is associated with lower odds of depression in individuals with rheumatoid arthritis, according to a study...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.